全文获取类型
收费全文 | 15391篇 |
免费 | 1323篇 |
国内免费 | 374篇 |
专业分类
耳鼻咽喉 | 111篇 |
儿科学 | 194篇 |
妇产科学 | 387篇 |
基础医学 | 455篇 |
口腔科学 | 83篇 |
临床医学 | 1428篇 |
内科学 | 1511篇 |
皮肤病学 | 51篇 |
神经病学 | 322篇 |
特种医学 | 301篇 |
外国民族医学 | 1篇 |
外科学 | 1179篇 |
综合类 | 2220篇 |
预防医学 | 662篇 |
眼科学 | 50篇 |
药学 | 1974篇 |
14篇 | |
中国医学 | 826篇 |
肿瘤学 | 5319篇 |
出版年
2024年 | 28篇 |
2023年 | 162篇 |
2022年 | 427篇 |
2021年 | 553篇 |
2020年 | 465篇 |
2019年 | 432篇 |
2018年 | 488篇 |
2017年 | 519篇 |
2016年 | 552篇 |
2015年 | 563篇 |
2014年 | 1198篇 |
2013年 | 1138篇 |
2012年 | 1109篇 |
2011年 | 1214篇 |
2010年 | 970篇 |
2009年 | 977篇 |
2008年 | 898篇 |
2007年 | 826篇 |
2006年 | 741篇 |
2005年 | 552篇 |
2004年 | 430篇 |
2003年 | 421篇 |
2002年 | 307篇 |
2001年 | 326篇 |
2000年 | 285篇 |
1999年 | 252篇 |
1998年 | 173篇 |
1997年 | 145篇 |
1996年 | 129篇 |
1995年 | 141篇 |
1994年 | 88篇 |
1993年 | 90篇 |
1992年 | 48篇 |
1991年 | 58篇 |
1990年 | 39篇 |
1989年 | 28篇 |
1988年 | 33篇 |
1987年 | 25篇 |
1986年 | 24篇 |
1985年 | 45篇 |
1984年 | 40篇 |
1983年 | 20篇 |
1982年 | 27篇 |
1981年 | 19篇 |
1980年 | 27篇 |
1979年 | 37篇 |
1978年 | 8篇 |
1977年 | 5篇 |
1976年 | 3篇 |
1972年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
泰素蒂加顺铂治疗进展期NSCLC的临床研究 总被引:5,自引:0,他引:5
目的观察泰素蒂加顺铂方案治疗进展期非小细胞肺癌的临床疗效、毒副作用。方法收集可评价疗效的进展期非小细胞肺癌50例,以泰素蒂加顺铂方案进行化疗,泰素蒂75 mg/m2静脉滴注,第1天;顺铂25 mg/m2~30 mg/m2静脉滴注,第2天~第5天,每3周为一个周期,2~3周期后评价疗效和毒副反应并随访。结果50例患者中,总有效率为50.0 %,其中初治病例为53.1 %,复治病例为44.4 %,初复治病例间差异无显著性(P >0.05)。中位缓解期为5个月。中位生存期为9.5个月,1年生存率为61.0 %。毒副反应主要为骨髓抑制,白细胞下降达Ⅲ度、Ⅳ度者52.0 %,血小板下降达Ⅲ度、Ⅳ度者为14.0 %。血红蛋白下降不严重。其他毒副反应还有脱发、过敏反应、水钠潴留、静脉炎、末梢神经炎、口腔炎、腹泻等,但发生率均较低。结论泰素蒂加顺铂方案治疗进展期非小细胞肺癌,特别是复发病例,临床疗效比较满意,毒副反应能够耐受。辅以G蛳CSF可防治重度的骨髓抑制,有较好的临床应用价值。 相似文献
12.
目的:比较康泉及康泉合用地塞米松预防急性白血病化疗所致的胃肠道反应的效果。方法:在同一方案的不同疗程,分别单用康泉或康泉合用地塞米松,随机对照,共观察110疗程。结果:康泉及康泉合用地塞米松对预防化疗所致急性呕吐有效率分别为69.5%和95.1%,有明显差异(P<0.01);对于迟发性呕吐两组的有效率分别为74.555%和91.83%,亦有明显差异。结论:康泉和地塞米松合用对控制急性和迟发性恶性呕吐优于康泉单用 相似文献
13.
黄芪、小柴胡冲剂联合辅酶Q10治疗病毒性心肌炎 总被引:1,自引:0,他引:1
目的观察黄芪、小柴胡冲剂联合辅酶Q10治疗病毒性心肌炎(VMC)的临床疗效.方法治疗组(30例)应用黄芪注射液、小柴胡冲剂和辅酶Q10;对照组(30例)用GIK极化液、辅酶Q10和维生素C,两组患者无禁忌证者均给予β-受体阻滞剂,钙拮抗剂和对症治疗.两组疗程均为3个月.结果治疗组临床症状和心律失常总有效率分别为73.3%和86.6%,高于对照组的43.3%和63.3%(p<0.05).结论黄芪、小柴胡冲剂联合辅酶Q10对VMC有较好疗效,且无明显不良反应. 相似文献
14.
Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation? 总被引:5,自引:0,他引:5
Herwig Pokorny Michael Gnant Susanne Rasoul-Rockenschaub Bernd Gollackner Birgit Steiner Günter Steger Rudolf Steininger Ferdinand Mühlbacher 《American journal of transplantation》2005,5(4):788-794
The aim of this prospective randomized study was to determine whether additional doxorubicin chemotherapy improves outcome in patients with hepatocellular carcinoma (HCCA) treated by liver transplantation. Stratification parameters were tumor stage (UICC I-IVa), gender, age 50 years, α-fetoprotein 20 ng/mL, cirrhosis and HbsAg status. For pre-operative chemotherapy doxorubicin (15 mg/m2 ) was given biweekly, intra-operative chemotherapy was a single dose administered before surgical manipulation. Post-operative chemotherapy from day 10 was as given preoperatively for a total dosage of 300 mg/m2 . Outcome parameters were overall survival (OS) and disease-free survival. Of the 75 consecutive patients who received liver transplantation for treatment of HCCA, 62 patients were enrolled. Thirty-four patients were randomized in the chemotherapy group; 28 patients were in the control group and transplanted only. OS rates at 5 years were 38% in the chemotherapy group and 40% in the control group, disease-free survival rates at 5 years 43% and 53%, respectively. Tumor stage and vascular invasion were identified as independent risk factors for recurrence of disease. Doxorubicin chemotherapy did not improve organ survival and disease-free survival in patients undergoing liver transplantation for HCCA. 相似文献
15.
T. Hammen F. Kerling M. Schwarz A. Stadlbauer O. Ganslandt B. Keck B. Tomandl A. Dörfler H. Stefan 《European journal of neurology》2006,13(5):482-490
Up to 30% of patients with temporal lobe epilepsy (TLE) remain without remarkable changes in MRI. In this study we investigated the role of (1)H-MR spectroscopy ((1)H-MRS) in lateralizing the affected hemisphere in the mentioned patient group. Twenty-two consecutive patients diagnosed with TLE were investigated by high resolution MRI and (1)H-MRS. We examined the incidence and diagnostic accuracy of temporal metabolite alterations determined by Linear Combination of Model Spectra (L C Model) via water reference. Metabolite values of each hemisphere of TLE patients were compared with healthy controls. Results of metabolite alterations were related to intensive video EEG focus localization. Reduction of N-acetylaspartate + N-acetylaspartyl-glutamate (tNAA) in the affected hemisphere revealed identification in six of nine patients (66%) with unilateral TLE. Group comparison revealed a significant reduction of tNAA (6.1+/-0.8*) in the involved temporal lobe compared with controls (6.67+/-0.4*, P=0.026). Choline levels were significantly increased in the affected hemisphere (1.42+/-0.17*) compared with healthy controls (1.22+/-0.17*, P=0.035). The results of our study show that (1)H-MRS is able to identify the affected hemisphere of MRI negative TLE patients and can be used as an additive tool in multimodal focus localization. 相似文献
16.
3H-胸苷酸掺入法对选择前列腺癌化疗方案的价值 总被引:1,自引:0,他引:1
目的为临床选择激素难治性前列腺癌(HRPC)的化疗方案提供参考.方法采用3H-胸苷酸(3H-TdR)掺入法检测了20例HRPC细胞对常用化疗药物的敏感性.结果HRPC对单药的体外敏感性依次为足叶乙苷(VP16)>阿霉素(ADM)、5-氟尿嘧啶(5-FU)、雌二醇氮芥(EMP)>长春花碱(VLB)>顺铂(DDP);二药联合可使敏感性进一步提高,依次为EMP加VP1 6、5-FU加ADM>EMP加VLB>5-FU加DDP三药联用抑瘤作用更强,EMP加VLB加APM、5 FU加ADM加DDP>EMP加VLB加DDP.结论3H-TdR掺入法有助于化疗方案的选择,对HRPC以联合化疗效果较好. 相似文献
17.
Objective: To analyze quantitatively the synergistic and antagonistic effects of combined oxymatrine (OMT) and 5-fluorouracil (5-GU)
on a cell line of human liver cancer (HepG2) with median-effect principle in vitro. Methods: The median-effect principle and MTT method were used in the quantitative analysis of effects of the two drugs. Results: Cytotoxic activity of the individual drugs enhanced as drug concentration increased. As fa=0.41, a CI equal to 1 indicated
additivity; fa<0.41, a CI less than 1 indicated synergy; and fa>0.41, a CI greater than 1 indicated antagonism. The sequence
of administration did not influence the cytotoxic activity of the combined antitumor drugs. The ratio of drug concentration
was a factor that can influence the killing effect. Conclusion: The combined drugs interaction (CI<1) was synergistic at lower concentration and antagonistic at higher concentration. The
ratio of drug concentration is a factor that can influence the killing effect.
Biography: HE Song(1965–), male, doctor of medicine, associate professor, Chongqing Medical University, majors in gastroenterology. 相似文献
18.
Two different hepatoma cell lines were incubated for 48h with chemotherapeutic drugs cisplatin, paclitaxel and 5-FU to determine their ability to induce cytotoxicity and DNA fragmentation as well as to modify the expression of some cell death-related genes that could be involved in the resistance to therapy. We observed that cisplatin and paclitaxel induced cytotoxicity, but significant differences between both cell lines, were found only in the case of paclitaxel. At 48h, apoptosis was clearly present in Hep3B cells treated with cisplatin and HepG2 cells treated with paclitaxel. 5-FU induced cytotoxicity in both cell lines but only at higher concentrations than the other two drugs, triggering apoptosis and necrosis in HepG2 cells and only necrosis in Hep3B. When a time course was performed for the first 8h of treatment to elucidate the initial mechanism of cell death responsible for DNA fragmentation, we observed that 5-FU in Hep3B, and cisplatin in both cell lines, induces primary necrosis, whereas at the concentration tested here, paclitaxel clearly triggers apoptosis in both cell lines. HepG2 cells were weakly sensitive to 5-FU in the first 8h of treatment, so the primary mechanism of cell death was not clear, but results seem to indicate that it could be apoptosis. At 48h, Bax was not up-regulated with any of the treatments, whereas cisplatin was able to induce Bcl-xL down-regulation in both cell lines. Treatment with 5-FU also down-regulated Bcl-xL in HepG2 cells. We also measured variations in the expression of survivin, an inhibitor of apoptosis that has also been involved in mitototic catastrophe. Hep3B cells seem to show an increase in protein levels with all treatments. Exposure to paclitaxel resulted in the highest effect. In the case of HepG2 cells, there was a decrease in survivin expression when cells were treated with 5FU and paclitaxel, both treatments showing complete loss of the protein. Using an antibody that recognizes unprocessed caspase-3, we observed that the enzyme was assumingly activated in HepG2 cells treated with 5FU and paclitaxel, but only weakly after treatment with cisplatin. Hep3B cells did not show activation since the levels of the pro-enzyme remained the same as that in the control. In conclusion, the three drugs tested in this study could induce cell death, with paclitaxel being more effective inducing apoptosis. 5FU was only effective at high doses and its mechanism seems to be primarily related to necrosis in Hep3B and probably apoptosis in HepG2. Cisplatin mechanism of cell death is probably mediated by the decrease in anti-apoptotic protein Bcl-xL whereas paclitaxel and 5FU are decreasing the apoptosis inhibitor survivin. According to pro-enzyme levels, caspase-3 was only activated in HepG2 cells, whereas in the case of Hep3B cells the mechanisms of toxicity appear to be caspase-3-independent at the time and concentrations tested in this study. The resistance of Hep3B cells to death induced by chemotherapy could be related to an increase in the expression of IAP survivin, which can decrease cell response to the treatment or even switch the type of death from apoptosis to another kind, making therapy less efficient. 相似文献
19.
目的探讨高能聚焦超声刀加氟脲嘧啶、四氢叶酸治疗晚期胰腺癌临床疗效及毒副作用。方法30例经病理学或细胞学确诊的晚期胰腺癌病人先用高能聚焦超声刀(HIFU)治疗,再予氟脲嘧啶、四氢叶酸联合化疗。氟脲嘧啶500mg/m^2加入5%GNS500ml静滴持续6小时以每天1次连用5天,CF(四氢叶酸)100mg/m^2加入生理盐水250ml静滴每天1次连用5天,28天为1周期,至少治疗2个周期。结果CR1例;PR9例;MR9例;NC5例;PD6例。总有效率63%。毒副作用主要消化道反应,其他副作用轻微。结论应用HIFU局部治疗胰腺癌同时合用四氢叶酸加氟脲嘧啶全身化疗近期疗效提高明显,止痛明显达75%,副反应小,值得应用。 相似文献
20.
术后恶心呕吐的危险因素分析及防治 总被引:10,自引:0,他引:10
恶心呕吐是术后常见的并发症,而且可引起切口裂开、吸入性肺炎、水电解质紊乱等严重后果。近年来,虽然对术后恶心呕吐(PONV)的发生机制进行了大量的研究,也出现了很多新型的抗呕吐药,但PONV发生率依然较高。PONV的治疗可分为非药物疗法和药物疗法,作者对药物疗法进行综述。 相似文献